Neurodevelopmental Implications of Fetal Exposure to Selective Serotonin Reuptake Inhibitors and Untreated Maternal Depression: Weighing Relative Risks

JAMA Psychiatry. 2016 Nov 1;73(11):1170-1172. doi: 10.1001/jamapsychiatry.2016.2705.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antidepressive Agents
  • Depression*
  • Depressive Disorder
  • Humans
  • Pregnancy Complications
  • Prenatal Exposure Delayed Effects
  • Risk
  • Serotonin Uptake Inhibitors*


  • Antidepressive Agents
  • Serotonin Uptake Inhibitors